Denali Share Price

Denali Share Price

NASDAQ: DNLI | Mid Cap | Healthcare
$18.44
+$0.25 (1.37%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Denali Stock Performance

Open
$17.95
Prev. Close
$18.19
Circuit Range
N/A
Day Range
$17.95 - $18.80
Year Range
$15.37 - $27.27
Volume
1,36,835
Average Traded
$18.49

Denali Share Price Today

As of 22 November 2026, Denali Therapeutics Inc.'s share price is $18.44. The stock opened at $17.95, compared to its previous close of $18.19. During today's trading session, Denali Therapeutics Inc.'s share price traded between $17.95 and $18.80, with an average price of $18.38. Over the past 52 weeks, the stock has recorded a high of $27.27 and a low of $15.37. In terms of performance, Denali Therapeutics Inc.'s share price has declined by 12.32% over the last six months and is down 5.29% on a year-on-year basis.

Denali Share Price Chart

Line chart of the Denali price trend over the selected period. The price rose overall, ranging from 17.95 to 18.84, ending at 18.46.
$17.95$18.80
L
Show Current Price
H

Denali Stock Fundamentals & Key Indicators

Market Cap
$3.18B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.00
Revenue (TTM)
$0.00
Return On Equity (TTM)
-34.56%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
151.14%

Denali Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$3.60$17.78
Net Profit-$128.55-$129.81-$127.55$65.74
Net Profit MarginN/AN/A-3543.06%369.74%
Income ChangeN/A-0.98%1.74%151.54%

Denali Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$108.46$330.53$0.00$0.00
Net Profit-$325.99-$145.22-$422.77-$512.54
Net Profit Margin-300.56%-43.94%N/AN/A
Income ChangeN/A55.45%-191.12%-21.23%

Denali Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets244.2509.7489.7887.92
Current Assets900.66864.441064.141372.32
Total Assets1144.851374.181153.921460.24
Non Current Liabilities32.7442.2944.9853.89
Current Liabilities98.35102.2177.98363.92
Total Liabilities131.09144.5122.96417.81
Shareholders' Equity1013.761229.681030.951042.43

Denali Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-412.6-347.69-357.99-244.72
Investing255.28-88.76249.31-141.39
Financing189.22484.317.82310.67

About Denali

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Denali Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$18.82
$18.47
-2.40%
Oct 2026
$20.57
$18.93
-8.69%
Sep 2026
$23.59
$20.73
-15.97%
Aug 2026
$22.80
$24.66
+7.19%
Jul 2026
$25.83
$23.01
-10.54%
Jun 2026
$20.86
$25.72
+22.30%
May 2026
$18.53
$21.03
+12.46%
Apr 2026
$19.57
$18.70
-2.50%
Mar 2026
$21.07
$19.18
-9.46%
Feb 2026
$21.27
$21.18
-2.69%
Jan 2026
$16.57
$21.77
+31.86%
Dec 2025
$19.13
$16.51
-15.20%

Denali Share Price FAQs